An immune dysregulation in MPN.

An immune dysregulation in MPN.

Item
http://www.wikidata.org/entity/Q38241495
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsInflammation as a Driver of Clonal Evolution in Myeloproliferative NeoplasmA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisRuxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients.The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasmsChronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsImmunological Consequences of JAK Inhibition: Friend or Foe?Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentGATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance
P2860

An immune dysregulation in MPN.

Item
http://www.wikidata.org/entity/Q38241495
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
An immune dysregulation in MPN.
@en
type
label
An immune dysregulation in MPN.
@en
prefLabel
An immune dysregulation in MPN.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
An immune dysregulation in MPN.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698